ZIKA

Robert Malone, MD, MS, CEO/CSO of Atheric Pharmaceuticals, LLC, discusses the benefits of repurposing drugs for emerging infectious diseases rather than going down the very long, costly road of developing new ones.

In case you missed them, here are our top 5 articles for the week of April 23, 2017.

Two studies published in the Centers for Disease Control and Prevention's Emerging Infectious Diseases journal have outlined just how local and travel-related Zika cases differ, as well as which testing method is most sensitive to Zika virus RNA.

The New England Journal of Medicine recently published two pieces on yellow fever. The first reports on the situation in the Americas, while the second recounts the case of a man from Angola who was found to be coinfected with yellow fever and Japanese encephalitis virus, although he reported no history of travel.

Adriano de Bernardi Schneider, MS, PhD Candidate, Contagion® Editorial Advisory Board Member, provides a brief snapshot into some of his work on mapping the evolution of the Zika virus.

Annelies Wilder-Smith, MD, PhD, professor at Lee Kong Chian School of Medicine in Singapore, discusses the strain of Zika that hit Singapore in 2016.

Experts are arguing that the President’s focus on national security needs to include healthcare response, before it’s too late.

Researchers report that Zika virus RNA was isolated in a number of Aedes albopictus mosquitoes in Bahia, Brazil.

David A. Schwartz, MD, MS Hyg, FCAP, clinical professor of pathology at Medical College of Georgia, Augusta University, explains how congenital infection with Zika virus differs from congenital infection with other viruses.

Researchers from The University of Texas Medical Branch at Galveston (UTMB) and Instituto Evandro Chagas (IEC) have published their findings on the live-attenuated vaccine candidate in the journal Nature Medicine.

David A. Schwartz, MD, MS Hyg, FCAP, clinical professor of pathology at Medical College of Georgia, Augusta University, explains his research, which focuses on mechanisms of transmission of the Zika virus from mother to child.

The Texas Department of State Health and Human Services has changed its testing recommendations for residents in six counties.

In case you missed them, here are our top 5 articles for the week of April 2, 2017.

Alice Panchaud, PharmD, PhD, clinical pharmacist and pharmacoepidemiologist, CHUV, Lausanne University Hospital, Switzerland, explains how researchers can anonymously enter patient data to the international Zika virus registry, which collects data on women exposed to the mosquito-borne virus during pregnancy.

News on Heliobacter pylori, Zika, Clostridium difficile, Powassan virus, and influenza make up the top 5 news articles from Contagion® in March 2017.

The Centers for Disease Control and Prevention (CDC) recently reported that they are seeing between 30 to 40 new cases of Zika virus in pregnant women in the United States each week.

Health officials in Florida declare that they are better prepared for a potential outbreak in their state as Zika vaccinations have begun in a multi-site Phase II/IIb clinical trial of VRC705 in areas of endemic Zika transmission throughout the world.

Carmen Zorrilla, MD, professor of obstetrics and gynecology, University of Puerto Rico, School of Medicine, discusses how the model of prenatal care centering works.

David A. Schwartz, MD, MS Hyg, FCAP, clinical professor of pathology at Medical College of Georgia, Augusta University, discusses Zika virus in indigenous populations.

In case you missed them, our top 5 articles for the week of March 12, 2017 are highlighted here.

The first international Open Science Prize has been awarded to Fred Hutchinson Cancer Research Center and University of Basel researchers for a software tool that is capable of tracking viral disease outbreaks.

According to the Centers for Disease Control and Prevention, residents in Miami-Dade, Broward, and Palm Beach counties have been at an increased risk of contracting Zika virus, since June 15, 2016.

Researchers remind us that the Zika virus infection does not only cause complications in developing fetuses, after reports identified that nine patients from Venezuela presented with cardiovascular complications linked with the mosquito-borne infection.

Annelies Wilder-Smith, MD, PhD, professor at Lee Kong Chian School of Medicine in Singapore, examines the effectiveness of personal protection against Zika, Dengue, and Chikungunya viruses.

Jean-Paul Gonzalez, MD, PhD, Deputy Director, Center of Excellence for Emerging and Zoonotic Animal Diseases (CEEZAD), Kansas State University, Adjunct Professor, Kansas State University, discusses the Zika virus from a historical perspective.